Investigating the enhancement of cisplatin cytotoxicity on 5637 cells by combination with mogoltacin

Toxicology in Vitro

Volumn 25, Issue 2, 2011, Pages 469-474

  Rassouli, Fatemeh Behnam ^a   Matin, Maryam M ^a   Iranshahi, Mehrdad ^b   Bahrami, Ahmad Reza ^a   Behravan, Javad ^b   Mollazadeh, Samaneh ^a   Neshati, Vajiheh ^a   Kalalinia, Fatemeh ^b  

^a FERDOWSI UNIVERSITY OF MASHHAD   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Apoptosis; Cisplatin; Cytotoxicity; Mogoltacin; Sesquiterpene Coumarin

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; HERBACEOUS AGENT; MITOXANTRONE; MOGOLTACIN; MULTIDRUG RESISTANCE PROTEIN; SESQUITERPENE DERIVATIVE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CELL SURVIVAL; CHROMATIN CONDENSATION; CONTROLLED STUDY; DNA DAMAGE; DRUG CYTOTOXICITY; DRUG STRUCTURE; FENNEL; FERULA BADRAKEMA; FRUIT;

ANTINEOPLASTIC AGENTS; CARCINOMA, TRANSITIONAL CELL; CELL LINE, TUMOR; CELL SURVIVAL; CISPLATIN; COUMARINS; DNA DAMAGE; DRUG RESISTANCE, MULTIPLE; HUMANS; MITOXANTRONE; SESQUITERPENES;

FERULA;

EID: 79151475706     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2010.11.015     Document Type: Article

References (35)

1. Ahmed A.A., Abd El-Razek M.H., Nassar M.I., Izuma S., Ohta S., Hirata T. Sesquiterpene coumarins from the roots of Ferula assa-foetida. Phytochemistry 2001, 58:1289-1295.
2. Barthomeuf C., Demeule M., Grassi J., Saidkhodjaev A., Beliveau R. Conferone from Ferula schtschurowskiana enhances vinblastine cytotoxicity in MDCK-MDR1 cells by competitively inhibiting P-glycoprotein transport. Planta Medica 2006, 72:634-639.
3. Behnam Rassouli F., Matin M.M., Iranshahi M., Bahrami A.R., Neshati V., Mollazadeh S., et al. Mogoltacin enhances the cytotoxicity of vincristine on TCC cell line. Phytomedicine 2009, 16:181-187.
4. Borst P., Evers R., Kool M., Wijnholds J. A family of drug transporters: the multidrug resistance-associated proteins. Journal of the National Cancer Institute 2000, 92:1295-1302.
5. Bukreeva T.V., Pimenov M.G. Coumarins from the roots of Ferula badrakema. Khim Prir Soedin 1991, 27:718-722.
6. Chee K.G., Cambio A., Lara P.N. Recent developments in advanced urothelial cancer. Current Opinion in Urology 2005, 15:342-349.
7. Choi C.H. ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal. Cancer Cell International 2005, 5:30-35.
8. Clifford S.C., Neal D.E., Lunec J. Alterations in expression of the multidrug resistance-associated protein (MRP) gene in high-grade transitional cell carcinoma of the bladder. British Journal of Cancer 1996, 73:659-666.
9. Cole S.P., Bhardwaj G., Gerlach J.H., Mackie J.E., Grant C.E., Almquist K.C., et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 1992, 258:1650-1654.
10. Cui Y., Konig J., Buchholz J.K., Spring H., Leier I., Keppler D. Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells. Molecular Pharmacology 1999, 55:929-937.
11. Evers R., Kool M., Deemter L., Jansen H., Calafat J., Oomen L.C., et al. Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA. Journal of Clinical Investigation 1998, 101:1310-1319.
12. Garcia Sar D., Montes-Bayón M., Aquado Ortiz L., Blanco-González E., Sierra L.M., Sanz-Medel A. In vivo detection of DNA adducts induced by cisplatin using capillary HPLC-ICP-MS and their correlation with genotoxic damage in Drosophila melanogaster. Analytical and Bioanalytical Chemistry 2008, 390:37-44.
13. Gottesman M.M. How cancer cells evade chemotherapy. Cancer Research 1993, 53:747-754.
14. Hooijberg J.H., Broxterman H.J., Kool M., Assaraf Y.G., Peters G.J., Noordhuis P. Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2. Cancer Research 1999, 59:2532-2535.
15. Jirsova K., Mandys V., Gispen W.H., Rudolf P. Cisplatin-induced apoptosis in cultures of human Schwann cells. Neuroscience Letters 2006, 392:22-26.
16. Kim W.J., Kakehi Y., Wu W.J., Fukumoto M., Yoshida O. Expression of multidrug resistance-related genes (mdrl, MRP, GST-pi and DNA topoisomerase II) in urothelial cancers. British Journal of Urology 1996, 78:361-368.
17. Kool M., de Haas M., Scheffer G.L., Scheper R.J., van Eijk M.J., Juijn J.A., et al. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Research 1997, 57:3537-3547.
18. Kubo H., Sumizawa T., Koga K., Nishiyama K., Takebayashi Y., Chuman Y., et al. Expression of the multidrug resistance-associated protein (MRP) gene in urothelial carcinomas. International Journal of Cancer 1998, 69:488-494.
19. Lee C.T., Smith C.A., Hall J.M., Waters W.B., Biermann J.S. Bladder cancer facts: accuracy of information on the internet. Journal of Urology 2003, 170:1756-1760.
20. Lorusso V., Silvestris N. Systemic chemotherapy for patients with advanced and metastatic bladder cancer: current status and future directions. Annals of Oncology 2005, 16:85-89.
21. Madureira A.M., Moinar A., Abreu P.M., Molnar J., Ferreira M.J. A new sesquiterpene-coumarin ether and a new abietane diterpene and their effects as inhibitors of P-glycoprotein. Planta Medica 2004, 70:828-833.
22. Merk O., Speit G. Detection of crosslinks with the comet assay in relationship to genotoxicity and cytotoxicity. Environmental and Molecular Mutagenesis 1999, 33:167-172.
23. Mollazadeh S., Matin M.M., Iranshahi M., Bahrami A.R., Neshati V., Behnam-Rassouli F. The enhancement of vincristine cytotoxicity by combination with feselol. Journal of Asian Natural Products Research 2010, 12:575-596.
24. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. Journal of Immunology 1983, 65:55-63.
25. Munoz-Martinez F., Lu P., Cortes-Selva F., Perez-Victoria J., Jimenez A., Ravelo A.G., et al. Celastraceae sesquiterpenes as a new class of modulators that bind specifically to human P-glycoprotein and reverse cellular multidrug resistance. Cancer Research 2004, 64:7130-7138.
26. Neshati V., Matin M.M., Iranshahi M., Bahrami A.R., Behravan J., Mollazadeh S., et al. Conferone enhances vincristine cytotoxicity in 5637 cell line. Zeitschrift für Naturforschung 2009, 64:317-322.
27. Rechinger K.H., Lemond J.M., Hedge I.C. Flora Iranica (Umbelliferae), Akademischev Druk-u. Verlagsanstalt, Graz-Austria 1994, 162:269-297.
28. Rosenberg J.E., Carroll P.R., Small E.J. Update on chemotherapy for advanced bladder cancer. Journal of Urology 2005, 174:14-20.
29. Sherman S.E., Lippard S.J. Structural aspect of platinum anticancer drug interaction with DNA. Chemical Reviews 1987, 87:1153-1181.
30. Shoemaker R.H., Curt G.A., Carney D.N. Evidence for multidrug resistant cells in human tumour cell populations. Cancer Treatment Reports 1983, 67:883-890.
31. Siegsmund M.J., Marx C., Seemann O., Schummer B., Steidler A., Toktomambetova L., et al. Cisplatin-resistant bladder carcinoma cells: enhanced expression of metallothioneins. Urological Research 1999, 27:157-163.
32. Singh N.P., McCoy M.T., Tice R.R., Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Experimental Cell Research 1988, 175:184-191.
33. Valle G.M., Appendino G., Nano G.M., Picci V. Prenylated coumarins and sesquiterpenoids from Ferula communis. Phytochemistry 1987, 26:253-258.
34. Yu T., Yang Y., Liu S., Yu H. Ultrasound increases DNA damage attributable to cisplatin in cisplatin-resistant human ovarian cancer cells. Ultrasound in Obstetrics and Gynecology 2009, 33:355-359.
35. Zamble D.B., Lippard S.J. Cisplatin and DNA repair in cancer chemotherapy. Trends in Biochemical Sciences 1995, 20:435-439.